Course Preview

  • Nursing
  • Advanced Practice Nursing
Hours: 3 Contact Hours (3 Pharm Hours)
  • C. Michael White, PharmD, FCP, FCCP
  • Leanne H. Fowler, DNP, MBA, AGACNP-BC, CCRN, CNE
Peer Reviewer(s): Jason Cross, PharmD
Item#: N1743
Contents: 1 Course Book (38 pages)
Expand your knowledge with the WS365 Online
Nursing Membership
Includes our entire library of nursing CE courses. 1 year for only $124

Antiplatelet Therapy: Implications for Advanced Practice Nursing

Price $22.95
Item # N1743
High-Level Content
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Release Date: December 6, 2016

Expiration Date: December 31, 2019

Antiplatelet medications are a commonly used class of medications in the U.S. for the prevention and/or treatment of many cardiovascular disorders. The drugs are used alone or in combination to achieve optimal patient outcomes. Prescribers must utilize fundamental knowledge of pharmacokinetics, pharmacodynamics, and pharmacotherapeutic considerations of antiplatelet medications to ensure (a) the identification of appropriate patients for this therapy, (b) the selection of the best agent to prescribe, and (c) the initiation of proper patient monitoring of this therapy.

This course is designed for nurse practitioners who prescribe and provide care to patients taking antiplatelet medications. The purpose of this course is to increase clinicians’ knowledge of antiplatelet medications to identify the best choices for the safe use of these medications.

This course is an extract of, and should not be taken in conjunction with N1752 - Anticoagulant, Antiplatelet, and Thrombolytic Therapies: Implications for Advanced Practice Nursing.


Course Objectives

  • Identify the role and significance of antiplatelet medications in patients with cardiovascular disorders.
  • Identify the physiological mechanisms associated with atherosclerosis and platelet thrombus formation.
  • Review the indications and considerations for prescribing specific antiplatelet medications.
  • Outline the evidence-based research involving patient selection, counseling, and monitoring for patients treated with antiplatelet medications.


C. Michael White, PharmD, FCP, FCCP, is professor and chair of the University of Connecticut School of Pharmacy’s Department of Pharmacy Practice in Storrs, Connecticut, and codirector of the Health Outcomes, Policy, and Evidence Synthesis research group at UConn and Hartford Hospital in Hartford, Connecticut, which houses one of only 13 Agency for Healthcare Research and Quality-designated Evidence-Based Practice Centers. Dr. White received his BS Pharm and PharmD degrees from the Albany College of Pharmacy in Albany, New York, and completed a cardiovascular clinical pharmacology fellowship at Hartford Hospital in Hartford, Connecticut. Dr. White has published more than 150 peer-reviewed articles, including publications in JAMA, Annals of Internal Medicine, Circulation, and Lancet. His research has been selected for the American Society of Health Systems Pharmacists Drug Therapy Research Award and the American Association of Colleges of Pharmacy Lyman Award. He is an American College of Clinical Pharmacy Young Investigator of the Year recipient and fellow of the American College of Clinical Pharmacologists and American College of Clinical Pharmacists. He is a contributing editor to the Annals of Pharmacotherapy, is on the editorial board for Pharmacy Practice News, and hosts a once-weekly show called “Ask the Pharmacist” on FOX61 in Hartford, Connecticut.

Leanne H. Fowler, DNP, MBA, AGACNP-BC, CCRN, CNE, graduated with a baccalaureate of science in nursing degree from Southern University in Baton Rouge, Louisiana, and a doctorate in nursing practice (DNP) specializing in nursing education and as an adult/gerontology acute care nurse practitioner from the University of South Alabama in Mobile. She conducted a successful quality improvement project for her DNP project titled Preventing Oversedation in the Mechanically Ventilated Adult via Interprofessional Implementation of the RASS Tool. She has 15 years of critical care nursing experience, 8 years of nursing education experience, 2 years as a board-certified adult/gerontology acute care nurse practitioner in hospital medicine, and 6 months in infectious diseases. She is ranked as an instructor at the LSU Health Sciences Center’s School of Nursing, where she is the course coordinator for the critical care course in the baccalaureate program and the BSN to DNP academic coordinator for the Adult-Gerontology Acute and Emergency Care Nurse Practitioner concentration. She is an active member in several professional organizations, including the American Association of Nurse Practitioners (nationally, as well as in the state and local chapters), American Association of Critical-Care Nurses (nationally, as well as the local chapter), Society of Critical Care Medicine (nationally, as well as the regional chapter), National League for Nursing, National Organization of Nurse Practitioner Faculty, and the Epsilon Nu chapter of Sigma Theta Tau.


Jason Cross, PharmD, is an Associate Professor of Pharmacy Practice at MCPHS University (Worcester/Manchester Campus). He completed his PharmD at the University of Rhode Island College of Pharmacy in 2001 and then completed a pharmacy practice residency at Umass Medical School/Umass Memorial Medical Center. Since 2002, he has been a faculty member at MCPHS, where he has maintained practice sites in ambulatory care, critical care, and adult internal medicine. Dr. Cross facilitates several courses within the Doctor of Pharmacy, Master of Physician Assistant, and Doctor of Physical Therapy programs. Dr. Cross currently practices adult internal medicine at Baystate Medical Center, Springfield, Massachusetts, and is the assistant director of the Pharmacy Practice Residency.

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.